On the horizon: Immunotherapy strategies for relapsed/refractory high-risk neuroblastoma

On the horizon: Immunotherapy strategies for relapsed/refractory high-risk neuroblastoma
October 13, 2020 ology
Current Status
Not Enrolled
Price
Free
Get Started

Thank you for participating in this educational activity on Thursday, October 15.

Please tap Login to Enroll and then Evaluation to complete the activity evaluation form to receive your accreditation certificate.

This educational activity is accredited for physician continuing medical education (AMA) and for continuing nursing education (ANCC-APRN) by the Postgraduate Institute for Medicine.